439096-29-4

Basic information

• Product Name: N-BENZYL-2-[(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL]BENZENECARBOXAMIDE
• Synonyms: N-BENZYL-2-[(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL]BENZENECARBOXAMIDE
• CAS NO: 439096-29-4
• Molecular Formula: C23H18N2O4
• Molecular Weight: 386.4
• Mol File: 439096-29-4.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-BENZYL-2-[(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL]BENZENECARBOXAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BENZYL-2-[(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL]BENZENECARBOXAMIDE(439096-29-4)
• EPA Substance Registry System: N-BENZYL-2-[(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL]BENZENECARBOXAMIDE(439096-29-4)

Safety Data

• Hazardous Substances Data: 439096-29-4(Hazardous Substances Data)

Upstream product

• 26513-80-4 2-(3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbonyl)-benzoic acid 
• 100-46-9 benzylamine 

Relevant articles and documents

RAF MODULATORS AND METHODS OF USE

The present invention relates to compounds of the Formula I, wherein G, A, X1, X2, X3, Z, E, Y, and X are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Raf. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.